Level C· Early human research exploring benefitsRetrospective StudyEurope PMCOpen access

A machine learning-based predictive model for stem cell therapy outcomes in plastic surgery

Xu L., Lian Y., Song Z., Zhang D., Zhai H.

Retrospective Study with a reported sample of 434 on Systemic / IV, published in Front Med (Lausanne) (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Retrospective Study
Journal
Front Med (Lausanne) (2025)
Reported sample size
434
Source database
Europe PMC
PMID
41480549
PMCID
PMC12753976
DOI
10.3389/fmed.2025.1683758

Abstract (original English)

Objective Stem cell therapy has emerged as a promising approach in plastic surgery, yet its efficacy varies markedly among individuals and lacks reliable predictive assessment tools. This study aimed to construct and validate a predictive model for assessing the therapeutic efficacy of stem cell therapy in plastic surgery by identifying key influencing factors through clinical data analysis and machine learning. Methods Patients who underwent stem cell therapy in the Department of Plastic Surgery from June 2021 to July 2024 were retrospectively included and randomly divided into a training set and a validation set at a 7:3 ratio. Baseline clinical data were collected, and independent influencing factors were screened via univariate analysis, followed by multivariate logistic regression and LASSO feature selection in the training set. Three machine learning models-random forest (RF), support vector machine (SVM), and K-nearest neighbors (KNN)-were constructed using Python 3.8.5 and the scikit-learn library, followed by performance validation in the validation set. Results A total of 620 patients who underwent stem cell therapy were included. In the training set ( n = 434), 262 cases (60.37%) showed effective treatment outcomes, while 112 cases (60.23%) were effective in the validation set ( n = 186). Multivariate logistic regression revealed that age, disease duration, diabetes

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research